7/12/18: “Whether you are setting a broken bone or suturing a laceration, injuries heal best when the tissue edges are perfectly lined up and repaired without gaps,” says Dr. Justin Saliman, founder and chief medical officer of Ceterix. “For the first time, orthopaedic surgeons can now apply this principle to meniscus tears with NovoStitch® Meniscal Repair Systems. We believe that by enabling simultaneous compression of the femoral and tibial sides of meniscus tears, the Ceterix technology can provide surgeons with greater confidence to repair tears that would have previously been considered non-repairable.”
Ceterix Orthopaedics Announces FDA Clearance of the NovoStitch Pro Meniscal Repair System, Offering Enhanced Features to Improve the Surgical Experience
4/16/18: Meniscus surgery is one of the most common surgical procedures in the United States, with one million performed annually.
New Patent for Transosteal Anchoring Methods for Meniscal Root Repair Announced by Ceterix Orthopaedics
3/26/18: Company reports the patent expands intellectual property porfolio for orthopedic applications.
Use of Ceterix NovoStitch® Plus System for Repair of Horizontal Meniscus Tears Supported by Three New Studies
Dr. Kenneth Brooks, orthopaedic surgeon and author of one of the reports. comments, “These publications illustrate the growing recognition that horizontal meniscus tears, previously deemed irreparable, can in fact be repaired with advanced technology."